ConductScience.org, home

Paper576161

Hypotensive sequelae of diazoxide and hydralazine therapy.

Henrich WL and 3 others. JAMA, 1977. Cited by 24 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Hypotensive sequelae of diazoxide and hydralazine therapy. Papers, record 576161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/576161

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hypotensive sequelae of diazoxide and hydralazine therapy.
PubMed
Journal
JAMA
PubMed
Year
1977
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
1.66
iCite
Revised in PubMed
2016-10-17
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Henrich WLW L
2Cronin RR
3Miller PDP D
4Anderson RJR J

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DiazoxideMajor topic
HydralazineMajor topic
HypotensionMajor topic
Adult
Drug Synergism
Female
Humans
Male
Middle Aged
Pregnancy

Source PubMed

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
6,840,160Antihypertensive effect of diazoxide given intravenously in small repeated doses.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6840160PubMed
6,264,332Decrease of some metabolic and physiologic effects of diazoxide by propranolol in rat.Naunyn Schmiedebergs Arch Pharmacol1981https://conductscience.org/library/papers/6264332PubMed
3,123,620Hypertensive emergencies and urgencies: definition, recognition, and management.J Gen Intern Med1988https://conductscience.org/library/papers/3123620PubMed
1,503,669Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy.Drug Saf1992https://conductscience.org/library/papers/1503669PubMed
526,401Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings.Br J Clin Pharmacol1979https://conductscience.org/library/papers/526401PubMed
328,207Pharmacokinetics and response to diazoxide in renal failure.Clin Pharmacokinet1977https://conductscience.org/library/papers/328207PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/576161

GET https://conductscience.org/api/papers/v1/576161/authors